News from: Missouri, California, C3, European Union and more.
The Daily Hit is a recap of the top financial news stories for Wednesday, September 18, 2024.
On the Site
Missouri issues yet another cannabis recall, rolls back hemp ban
The state’s Department of Health and Senior Services will focus its efforts on “misbranded” products rather than intoxicating ones.
Proposed California intoxicating hemp ban may wind up in court
Advocates say the new emergency rules will eliminate access to high-CBD products.
Banned C3 team has new IPO for Canadian markets
The IPO was announced the day after the executives filed an appeal regarding the ban and accompanying fines.
Washington DC moves toward gray market cannabis crackdown
City leaders want to ramp up enforcement on so-called I-71 shops.
EU initiative begins bid to open access to psychedelic therapies
The initiative must collect 1 million signatures within a year to trigger the European Commission to take action.
In Other News
Cannabis Cured
One week after Maine regulators recalled a handful of cannabis products for failing mold and yeast tests, it remains unclear how the contaminated products made it to the market. The recall, announced last week, impacts one strain of cannabis flower and three strains of pre-rolls, all of which were produced by Cannabis Cured, a cultivator and retailer headquartered in Fairfield.
Flora Growth Corp.
Flora Growth Corp. entered into a strategic supply agreement with Blossom Genetics to bring Colombian medical cannabis to the German market.
Tilray
Tilray Medical, a division of Tilray Brands, announced on Wednesday that several Redecan EU-GMP certified medical cannabis products are now available for medical cannabis patients in Australia.
[[{“value”:”News from: Missouri, California, C3, European Union and more.
The post The Daily Hit: September 18, 2024 appeared first on Green Market Report.”}]] Read More